Analysis of Tesla's Capital Investment and Its Impact on SpaceX IPO Prospects

By Patricia Miller

Apr 23, 2026

2 min read

Tesla's $25B capex for 2026 may strain SpaceX IPO plans. Current market for SpaceX public offering shows rising confidence.

Tesla's projected capital expenditures of $25 billion for 2026, mainly to support the TERAFAB project, could introduce financial pressure that might impact SpaceX's potential IPO plans. Currently, the likelihood of SpaceX going public by June 30 stands at 70.5%, a rise from 68% a week earlier.

With a notable disparity between the contracts for June 30 and September 30, where the latter shows a 92.5% positive forecast, the market indicates expectations for a significant event post-June that may relate to Tesla's cash flow demands. The December 31 contract is also reflecting a solid 91.5% confidence level, maintaining a flat position compared to September.

The increasing capital expenditure might further shape perceptions about NVIDIA's status as the top company by June 30, with a current confidence standing at 90.5%. There is a potential risk for NVIDIA, given Tesla's recent focus on AI chip production, which could diminish NVIDIA's market lead. This is a pivotal consideration for traders assessing market contracts.

In terms of trading activity, the volume remains moderate with combined face values of $3,658 for the SpaceX IPO and $53,053 for NVIDIA's contract. The movements observed indicate that even minimal order flow can impact prices significantly at this liquidity level.

Tesla's aggressive approach to capital spending, particularly amid the ongoing geopolitical uncertainties, underscores its commitment to achieving semiconductor independence. Investors contemplating a position on a SpaceX IPO by the June deadline might view the 70¢ option favorably, perhaps yielding a 1.42x return if successful. This investment hinges on the expectation that Tesla's cash flow challenges will not postpone the IPO.

It is crucial for investors to keep an eye on upcoming SEC filings, financial disclosures from SpaceX, and Tesla’s updates regarding the TERAFAB timeline. These factors will likely influence market dynamics and investor sentiment.

Important Notice And Disclaimer

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.